Modified Glucose‐Insulin‐Potassium Regimen Provides Cardioprotection With Improved Tissue Perfusion in Patients Undergoing Cardiopulmonary Bypass Surgery

BACKGROUND: Laboratory studies demonstrate glucose‐insulin‐potassium (GIK) as a potent cardioprotective intervention, but clinical trials have yielded mixed results, likely because of varying formulas and timing of GIK treatment and different clinical settings. This study sought to evaluate the effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Kun, Zhang, Yue, Li, Jia, Cui, Qin, Zhao, Rong, Chen, Wensheng, Liu, Jincheng, Zhao, Bijun, Wan, Yi, Ma, Xin-Liang, Yu, Shiqiang, Yi, Dinghua, Gao, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335515/
https://www.ncbi.nlm.nih.gov/pubmed/32151220
http://dx.doi.org/10.1161/JAHA.119.012376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335515/
https://www.ncbi.nlm.nih.gov/pubmed/32151220
http://dx.doi.org/10.1161/JAHA.119.012376

Ejemplares similares